论文部分内容阅读
目的观察豁痰化瘀方治疗冠心病非经皮冠状动脉介入治疗术患者的临床疗效及可能作用机制。方法 80例患者随机分为对照组(36例)和治疗组(44例),对照组采用冠心病治疗指南规范治疗,治疗组在对照组基础上加用豁痰化瘀方,每日1剂,两组均治疗30天。观察两组心绞痛疗效及心电图疗效,治疗前后采用西雅图量表评价患者生活质量,检测血浆同型半胱氨酸水平的变化。结果治疗组心绞痛疗效总有效率为88.6%,对照组为72.2%;治疗组心电图疗效总有效率为90.9%,对照组为63.9%;治疗组患者心绞痛疗效及心电图疗效均优于对照组(P<0.05)。治疗组治疗后西雅图量表评分中心绞痛稳定状态、心绞痛发作情况及治疗满意程度评分均较本组治疗前明显升高(P<0.05或P<0.01);对照组治疗后心绞痛稳定状态、心绞痛发作情况评分亦较本组治疗前升高(P<0.01);两组治疗后组间比较,治疗组心绞痛发作情况评分高于对照组(P<0.05)。两组治疗后血浆同型半胱氨酸均较本组治疗前降低(P<0.01),治疗组较对照组降低更显著(P<0.05)。结论豁痰化瘀方联合西药治疗冠心病非经皮冠状动脉介入治疗患者可明显提高临床疗效,改善生活质量,其作用可能与降低血浆同型半胱氨酸水平有关。
Objective To observe the clinical efficacy and possible mechanism of “Phlegm Huayu Recipe” in the treatment of patients with coronary artery disease without percutaneous coronary intervention. Methods Eighty patients were randomly divided into control group (n = 36) and treatment group (n = 44). The control group was given standard treatment of coronary heart disease. The treatment group was treated with traditional Chinese medicine of tonifying phlegm and resolving stasis on day one , Both groups were treated for 30 days. The angina pectoris effect and electrocardiogram curative effect were observed in both groups. Before and after treatment, the Seattle scale was used to evaluate the quality of life and the plasma homocysteine levels were measured. Results The total effective rate of angina pectoris in treatment group was 88.6% and that in control group was 72.2%. The total effective rate of electrocardiogram in treatment group was 90.9% and that in control group was 63.9%. The effect of angina pectoris and electrocardiogram in treatment group were better than those in control group (P <0.05). After treatment, the scores of angina pectoris, angina pectoris and satisfaction of patients in the treatment group were significantly higher than those before treatment in the Seattle Scale (P <0.05 or P <0.01); the control group had stable angina pectoris and angina pectoris The score of the condition was also higher than that of the control group before treatment (P <0.01). The score of angina pectoris in the treatment group was higher than that in the control group after treatment (P <0.05). The levels of plasma homocysteine in both groups were significantly lower than those in the control group before treatment (P <0.01), and those in the treatment group decreased more significantly than those in the control group (P <0.05). ConclusionThorting phlegm and resolving stasis combined with Western medicine in patients with coronary artery disease without percutaneous coronary intervention can significantly improve the clinical efficacy and improve the quality of life, its role may be related to lower plasma homocysteine levels.